Psy Therapeutics, Inc is a preclinical biopharmaceutical company committed to creating new futures in central nervous system (CNS) treatment and care. To further our mission, Psy has developed a robust and innovative pipeline of high potential CNS therapeutics focused on anxiety disorders, depression, and dementia. The company’s highly accomplished and experienced team of neuroscientists, clinicians and business builders combine their proven skills with validated cutting-edge technologies and strategic collaborations to advance our research programs and create significant value for our patients, supporters and all other stakeholders.